Iranian Journal of Radiology

Published by: Kowsar

Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Symptomatic Uterine Fibroids and Normal Uterus: A Feasibility Study

Soheila Majd 1 , Basri Johan Jeet Abdullah 1 , * , Sazilah Ahmad Sarji 1 , Chai Hong Yeong 1 and Noor Azmi Mat Adenan 2
Authors Information
1 Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2 Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
Article information
  • Iranian Journal of Radiology: April 2017, 14 (2); e36213
  • Published Online: November 27, 2016
  • Article Type: Research Article
  • Received: January 10, 2016
  • Revised: July 29, 2016
  • Accepted: November 15, 2016
  • DOI: 10.5812/iranjradiol.36213

To Cite: Majd S, Johan Jeet Abdullah B, Ahmad Sarji S, Hong Yeong C, Azmi Mat Adenan N. Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Symptomatic Uterine Fibroids and Normal Uterus: A Feasibility Study, Iran J Radiol. 2017 ; 14(2):e36213. doi: 10.5812/iranjradiol.36213.

Copyright © 2016, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Gaustad JV, Brurberg KG, Simonsen TG, Mollatt CS, Rofstad EK. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia. 2008; 10(4): 354-62[DOI]
  • 2. Kim YE, Lim JS, Choi J, Kim D, Myoung S, Kim MJ, et al. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression. Korean J Radiol. 2013; 14(6): 878-85[DOI][PubMed]
  • 3. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging. 2003; 18(4): 467-77[DOI][PubMed]
  • 4. Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Newstead GM. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med. 2008; 59(4): 747-54[DOI][PubMed]
  • 5. Agner SC, Soman S, Libfeld E, McDonald M, Thomas K, Englander S, et al. Textural kinetics: a novel dynamic contrast-enhanced (DCE)-MRI feature for breast lesion classification. J Digit Imaging. 2011; 24(3): 446-63[DOI][PubMed]
  • 6. Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol. 2011; 196(1): 210-7[DOI][PubMed]
  • 7. Rezaei S, Rad HS. A Review Study on the Efficacy of Quantitative DCE-MRI in Breast Lesion Diagnosis. Iran J Radiol. 2014; 11(1)[DOI]
  • 8. Levy BS. Modern management of uterine fibroids. Acta Obstet Gynecol Scand. 2008; 87(8): 812-23[DOI][PubMed]
  • 9. Abdullah B, Subramaniam R, Omar S, Wragg P, Ramli N, Wui A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment for uterine fibroids. Biomed Imaging Interv J. 2010; 6(2): 15[DOI][PubMed]
  • 10. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007; 8(1): 63-74[DOI][PubMed]
  • 11. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer. 2007; 96(2): 189-95[DOI][PubMed]
  • 12. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV. Estimating kinetic parameters from dynamic contrast-enhanced T 1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999; 10(3): 223-32
  • 13. Gallagher FA. An introduction to functional and molecular imaging with MRI. Clin Radiol. 2010; 65(7): 557-66[DOI][PubMed]
  • 14. Bhatnagar P, Subesinghe M, Patel C, Prestwich R, Scarsbrook AF. Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer. Radiographics. 2013; 33(7): 1909-29[DOI][PubMed]
  • 15. Dewhirst MW, Ong ET, Braun RD, Smith B, Klitzman B, Evans SM, et al. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer. 1999; 79(11-12): 1717-22[DOI][PubMed]
  • 16. Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol. 1998; 46(2): 135-46[DOI][PubMed]
  • 17. Agrawal S, Awasthi R, Singh A, Haris M, Gupta RK, Rathore RK. An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers. Clin Radiol. 2012; 67(9): 1-5[DOI][PubMed]
  • 18. Newbold K, Castellano I, Charles-Edwards E, Mears D, Sohaib A, Leach M, et al. An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; 74(1): 29-37[DOI][PubMed]
  • 19. Funaki K, Fukunishi H, Funaki T, Kawakami C. Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol. 2007; 14(5): 616-21[DOI][PubMed]
  • 20. Tempany CM. From the RSNA refresher courses: Image-guided thermal therapy of uterine fibroids. Radiographics. 2007; 27(6): 1819-26[DOI][PubMed]
  • 21. Kim YS, Lim HK, Kim JH, Rhim H, Park BK, Keserci B, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol. 2011; 46(10): 639-47[DOI][PubMed]
  • 22. Yoon SW, Lee C, Kim KA, Kim SH. Contrast-Enhanced Dynamic MR Imaging of Uterine Fibroids as a Potential Predictor of Patient Eligibility for MR Guided Focused Ultrasound (MRgFUS) Treatment for Symptomatic Uterine Fibroids. Obstet Gynecol Int. 2010; 2010[DOI][PubMed]
  • 23. Thomassin-Naggara I, Darai E, Nassar-Slaba J, Cortez A, Marsault C, Bazot M. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr. 2007; 31(2): 236-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments